How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors
Developing therapies for solid tumors remains a challenging task due to the heterogeneity of tumor tissues and the high variability between individual patients. Collecting tissue samples to analyze the differences between healthy and tumor tissues is a …